AAAAAA

   
Results: 1-25 | 26-39 |
Results: 26-39/39

Authors: Benet, LZ Izumi, T Zhang, YC Silverman, JA Wacher, VJ
Citation: Lz. Benet et al., Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery, J CONTR REL, 62(1-2), 1999, pp. 25-31

Authors: Mizuma, T Benet, LZ Lin, ET
Citation: T. Mizuma et al., Interaction of human serum albumin with furosemide glucuronide: a role of albumin in isomerization, hydrolysis, reversible binding and irreversible binding of a 1-O-acyl glucuronide metabolite, BIOPHARM DR, 20(3), 1999, pp. 131-136

Authors: Jacobsen, W Kirchner, G Hallensleben, K Mancinelli, L Deters, M Hackbarth, I Benet, LZ Sewing, KF Christians, U
Citation: W. Jacobsen et al., Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver, DRUG META D, 27(2), 1999, pp. 173-179

Authors: Jager, W Correia, MA Bornheim, LM Mahnke, A Hanstein, WG Xue, LL Benet, LZ
Citation: W. Jager et al., Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: Implication for cyclosporine metabolism, DRUG META D, 27(12), 1999, pp. 1505-1511

Authors: Salphati, L Benet, LZ
Citation: L. Salphati et Lz. Benet, Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A, XENOBIOTICA, 29(2), 1999, pp. 171-185

Authors: Benet, LZ Bennett, WM
Citation: Lz. Benet et Wm. Bennett, Generic immunosuppressants - Introduction, TRANSPLAN P, 31(3A), 1999, pp. 1S-1S

Authors: Benet, LZ
Citation: Lz. Benet, Understanding bioequivalence testing, TRANSPLAN P, 31(3A), 1999, pp. 7S-9S

Authors: Benet, LZ
Citation: Lz. Benet, Relevance of pharmacokinetics in narrow therapeutic index drugs, TRANSPLAN P, 31(3), 1999, pp. 1642-1644

Authors: Hausen, B Boeke, K Berry, GJ Segarra, I Benet, LZ Christians, U Morris, RE
Citation: B. Hausen et al., Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to ratlung allograft recipients - Potentiation of immunosuppressive efficacy andimprovement of tolerability by staggered versus simultaneous treatment, TRANSPLANT, 67(7), 1999, pp. 956-962

Authors: Zhang, YC Guo, XS Lin, ET Benet, LZ
Citation: Yc. Zhang et al., In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes, PHARMACOL, 58(3), 1999, pp. 147-159

Authors: Jacobsen, W Kirchner, G Hallensleben, K Mancinelli, L Deters, M Hackbarth, I Baner, K Benet, LZ Sewing, KF Christians, U
Citation: W. Jacobsen et al., Small intestinal metabolism of the 3-hydroxy-3-methylglutary-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin, J PHARM EXP, 291(1), 1999, pp. 131-139

Authors: Serkova, N Litt, L James, TL Sadee, W Leibfritz, D Benet, LZ Christians, U
Citation: N. Serkova et al., Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy, J PHARM EXP, 289(2), 1999, pp. 800-806

Authors: Segarra, I Brazelton, TR Guterman, N Hausen, B Jacobsen, W Morris, RE Benet, LZ Christians, U
Citation: I. Segarra et al., Development of a high-performance liquid chromatographic electrospray massspectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin, J CHROMAT B, 720(1-2), 1998, pp. 179-187

Authors: Tsunoda, SM Harris, RZ Mroczkowski, PJ Benet, LZ
Citation: Sm. Tsunoda et al., Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women, J CLIN PHAR, 38(12), 1998, pp. 1137-1143
Risultati: 1-25 | 26-39 |